Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Global Health Ltd

MEDANTA
NSE
1,142.95
0.47%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Guidance Tracker
Alert
Watchlist
Note

Global Health Ltd

MEDANTA
NSE
1,142.95
0.47%
29 Apr '26, 4:00 PM
Company Overview
Guidance Tracker
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
30,728Cr
Close
Close Price
1,142.95
Industry
Industry
Hospitals
PE
Price To Earnings
59.78
PS
Price To Sales
7.35
Revenue
Revenue
4,182Cr
Rev Gr TTM
Revenue Growth TTM
17.16%
PAT Gr TTM
PAT Growth TTM
1.28%
Peer Comparison
How does MEDANTA stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
MEDANTA
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
7077808448368098619579439311,0311,0991,121
Growth YoY
Revenue Growth YoY%
35.726.324.320.514.410.413.312.815.219.714.918.8
Expenses
ExpensesCr
540595631621629675728706707784868904
Operating Profit
Operating ProfitCr
167184213216179186228238225247231217
OPM
OPM%
23.623.725.225.822.221.623.925.224.123.921.019.4
Other Income
Other IncomeCr
2515211827221816-272036-15
Interest Expense
Interest ExpenseCr
201820181818161615141722
Depreciation
DepreciationCr
384043444547494849455061
PBT
PBTCr
133141171172143144181189133208200120
Tax
TaxCr
323945491637504632494125
PAT
PATCr
10110212512412710613114310115915895
Growth YoY
PAT Growth YoY%
475.973.846.153.326.04.24.515.6-20.449.621.1-33.5
NPM
NPM%
14.313.114.814.815.812.313.715.110.915.414.48.5
EPS
EPS
3.83.84.74.64.74.04.95.33.85.95.93.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
1,3431,4561,5001,4472,1672,7103,2753,6924,182
Growth
Revenue Growth%
8.43.1-3.649.825.120.912.713.3
Expenses
ExpensesCr
1,2231,2881,3141,2551,7162,0822,4762,8153,263
Operating Profit
Operating ProfitCr
121168187191451628799877920
OPM
OPM%
9.011.512.413.220.823.224.423.822.0
Other Income
Other IncomeCr
495044313949752914
Interest Expense
Interest ExpenseCr
243352677978746567
Depreciation
DepreciationCr
86102115123130150173194205
PBT
PBTCr
60836432281449627647661
Tax
TaxCr
273228484123149166147
PAT
PATCr
33513629196326478481514
Growth
PAT Growth%
55.7-29.2-20.7581.166.246.60.76.8
NPM
NPM%
2.53.52.42.09.112.014.613.012.3
EPS
EPS
6.72.11.41.17.812.617.817.919.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
484949505154545454
Reserves
ReservesCr
1,1361,2141,2681,3001,5652,3752,8523,3333,654
Current Liabilities
Current LiabilitiesCr
334296358405419573618619721
Non Current Liabilities
Non Current LiabilitiesCr
4328399599071,1101,115781760979
Total Liabilities
Total LiabilitiesCr
1,9842,4302,6662,6943,1464,1164,3044,7665,410
Current Assets
Current AssetsCr
4724894795028121,5791,5091,5331,729
Non Current Assets
Non Current AssetsCr
1,5121,9412,1882,1922,3342,5362,7953,2333,681
Total Assets
Total AssetsCr
1,9842,4302,6662,6943,1464,1164,3044,7665,410

Cash Flow

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
63166175242311645612624
Investing Cash Flow
Investing Cash FlowCr
-69-249-87-239-421-342-441-721
Financing Cash Flow
Financing Cash FlowCr
997-1-81160346-514-97
Net Cash Flow
Net Cash FlowCr
31487-7850648-343-194
Free Cash Flow
Free Cash FlowCr
-81-133-1310038409335110
CFO To PAT
CFO To PAT%
190.5322.7481.9839.3158.6197.7128.0129.6
CFO To EBITDA
CFO To EBITDA%
52.098.793.8126.369.1102.776.671.1

Ratios

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
0000014,11135,54232,182
Price To Earnings
Price To Earnings
0.00.00.00.00.043.374.366.9
Price To Sales
Price To Sales
0.00.00.00.00.05.210.88.7
Price To Book
Price To Book
0.00.00.00.00.05.812.29.5
EV To EBITDA
EV To EBITDA
1.23.03.63.41.322.244.036.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
76.777.778.375.974.976.976.876.2
OPM
OPM%
9.011.512.413.220.823.224.423.8
NPM
NPM%
2.53.52.42.09.112.014.613.0
ROCE
ROCE%
5.25.75.14.413.214.818.917.4
ROE
ROE%
2.84.12.82.112.113.416.414.2
ROA
ROA%
1.72.11.41.16.27.911.110.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Global Health Limited, operating under the **Medanta** brand, is one of India’s largest private multi-specialty tertiary and quaternary care providers. With a strategic footprint in **North and East India**, Medanta specializes in high-acuity, complex medical care across key specialties including **cardiology, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver and kidney transplants, and urology**. Founded by **Dr. Naresh Trehan**, a renowned cardiovascular surgeon and recipient of prestigious national awards such as the **Padma Bhushan, Padma Shri, and Dr. B.C. Roy Award**, the company was established to transform India’s healthcare delivery through an integrated, multidisciplinary, doctor-led model. Since its inception in 2009 with the launch of its 1,400-bed flagship “Medicity” in Gurugram, Medanta has evolved into a **pan-India healthcare network** serving over **400 million people**. --- ### **Network & Infrastructure (as of June 30, 2025)** - **5 Operational Hospitals** in: - Gurgaon (Haryana) - Lucknow (Uttar Pradesh) - Patna (Bihar) - Indore (Madhya Pradesh) - Ranchi (Jharkhand) - **Total Installed Bed Capacity:** **3,062 beds** - **Total Operated Area:** **3.062 million sq. ft.** - **6th Hospital (Under Construction):** 550-bed facility in **Noida**, scheduled to open in **Q2 FY26**. The company is actively expanding, with **four greenfield and O&M hospitals under development** in **Mumbai (Oshiwara), New Delhi (Pitampura), South Delhi (GK), and Guwahati (Assam)**—collectively adding **~2,000 new beds** over the next 3–4 years. --- ### **Strategic Growth & Expansion** Medanta is executing a **clear, two-pronged growth strategy**: 1. **Capacity Expansion** in existing hospitals via brownfield additions (e.g., **~1,000 new beds** planned over two years in Noida, Lucknow, Patna, and Ranchi). 2. **Greenfield & O&M Projects** in underserved and high-demand markets: - **Guwahati (400 beds):** Medanta’s **first entry into Northeast India**, strategically located on NH-27 to serve over **50 million people**. Includes robotic care and transplant services. - **Mumbai (500+ beds):** Acquired 9,288 sq. m in Oshiwara through auction (**INR 131.16 crores**), with a **total project cost of ~INR 1,200 crores**. - **Pitampura, Delhi (750 beds):** Joint O&M project with the **Dr. Narayan Dutt Shirmali Foundation** and DLF, expected in **~4 years**. - **South Delhi (400 beds):** 50:50 JV with **DLF**; Medanta retains operational control. The company aims to **double its bed capacity to ~6,000 beds** within the next four years, driven by both organic expansion and strategic capital-light O&M models. --- ### **Clinical Excellence & Key Milestones** Medanta is a **leader in advanced medical procedures** and innovation: - **World-Class Accreditations**: JCI (4 consecutive cycles), NABH, NABL at Gurugram. - **Key Procedures Performed**: - India’s first **bloodless bone marrow transplant** on a Jehovah's Witness patient. - First **3D-printed titanium vertebrae implant** (C1–C3 replacement). - Robotic-assisted **deep brain stimulation for Parkinson’s** (awake surgery). - **NexCAR19 CAR T-Cell therapy** for high-risk lymphoma (first indigenous success). - **Organ Transplants**: - Performed **730+ transplants** to date, including pediatric liver transplants and robotic donor hepatectomies. - **Innovation in Technology**: - Pioneering use of **CyberKnife VSI**, **Da Vinci Robotic System**, **intraoperative MRI (Brain Suite)**, and **Varian EDGE** for sub-millimeter radiation precision. - Launched **India’s first Varian EDGE in North India** (Lucknow & Patna). Medanta has treated **over 2.5 million patients** from India and **130+ countries**, establishing itself as a **global destination for medical value tourism**. --- ### **Integrated Healthcare Ecosystem** Beyond hospitals, Medanta has built a **comprehensive, vertically integrated care model**: - **Medanta Clinics**: 8 multi-specialty outpatient clinics. - **Medanta Labs**: 11 diagnostic labs + **300+ sample collection centers**; expanding into Bihar and UP. - **Retail Pharmacies**: 8 operational; planned expansions to 18+. - **Home Care Services**: Available in Gurugram, Lucknow, Patna, Indore; includes ICU-at-home, remote monitoring, and nursing. - **Digital Health**: - **24x7 e-ICU Command Centre** across 30+ specialties. - **Teleconsultation, e-Clinic app, and EMR platform** with secure record access. - **AI integration** with partners like **Qure.ai** for radiology diagnostics and **DocBox** for cardiac monitoring. --- ### **Operational & Governance Model** - **Doctor-Led Model**: >90% of doctors are **full-time and exclusive**, ensuring care continuity. Departmental heads have clinical autonomy under a **joint clinical leadership committee**. - **Medanta Model of Care**: Collaborative, multi-specialty approach focusing on patient-centric treatment and complex case management. - **Digital Backbone**: Unified EHR, AI-driven predictive analytics, and custom mobile apps for doctors, patients, and nurses. - **Sustainability & Innovation**: - Hospitals built with **modular, scalable designs** (~1,000 sq. ft. per bed). - Noida hospital pre-certified for **Green Building Certification (IGBC)**. --- ### **Leadership & Vision** - **Dr. Naresh Trehan**: Founder and Chairman; pioneer of integrated care in India. - **Pankaj Sahni**: CEO since 2013; oversaw IPO in **November 2022** and network expansion. - Vision: Deliver **accessible, affordable, and high-quality healthcare** through innovation, technology, and scalable infrastructure. --- ### **Market Position & Recognition** - **Newsweek’s #1 Private Hospital in India** for **six consecutive years**. - Largest private hospitals in **Uttar Pradesh (Lucknow)**, **Bihar (Patna)**, and **Delhi-NCR (Gurugram)**. - Recognized for **robotic surgery leadership** and clinical breakthroughs in complex transplants and cancer care. --- ### **Financial & Operational Highlights** - **Revenue Streams**: Tertiary/quaternary care across 30+ specialties; ~82% from **cash and TPA**. - **Government Empanelment**: Active participation in **Ayushman Bharat, CGHS, and PSU schemes** to expand affordability. - **Cost Model (Lucknow)**: Fixed-cost physician model supports **scalable margins** with rising volumes. ---